We are live on ! Find out more
NC

NewSquare Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 34.37%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+34.37%
3 Year Est. Return
+76.51%
5 Year Est. Return
+87.8%
10 Year Est. Return
+247.65%
AUM
$802M
AUM Growth
+$1.56M
Cap. Flow
-$61.5M
Cap. Flow %
-7.68%
Top 10 Hldgs %
29.79%
Holding
886
New
409
Increased
133
Reduced
137
Closed
55

Sector Composition

Rank Sector Weight
1 Financials 6.47%
2 Consumer Staples 5.38%
3 Healthcare 4.97%
4 Technology 4.25%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRMW
751
DELISTED
Primo Water Corporation
PRMW
$155 ﹤0.01%
10
EMBC icon
752
Embecta
EMBC
$269M
$152 ﹤0.01%
6
-50
-89% -$1.53K
RETA
753
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$152 ﹤0.01%
+4
New +$138
NOTV
754
DELISTED
Inotiv
NOTV
$148 ﹤0.01%
+30
New +$373
SCHE icon
755
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$142 ﹤0.01%
6
EWZ icon
756
iShares MSCI Brazil ETF
EWZ
$8.57B
$140 ﹤0.01%
5
MFGP
757
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$139 ﹤0.01%
22
BNBX
758
DELISTED
BNB PLUS CORP
BNBX
0
TW icon
759
Tradeweb Markets
TW
$21.9B
$130 ﹤0.01%
2
AQST icon
760
Aquestive Therapeutics
AQST
$531M
$117 ﹤0.01%
+130
New +$122
MUX icon
761
McEwen Inc
MUX
$1.18B
$117 ﹤0.01%
+20
New +$93
CGC
762
Canopy Growth
CGC
$431M
$116 ﹤0.01%
+5
New +$154
GILT icon
763
Gilat Satellite Networks
GILT
$895M
$116 ﹤0.01%
+20
New +$113
BCLI
764
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$115 ﹤0.01%
+5
New +$187
HIVE
765
HIVE Digital Technologies
HIVE
$750M
$115 ﹤0.01%
+80
New +$204
CDNA icon
766
CareDx
CDNA
$2.45B
$114 ﹤0.01%
+10
New +$148
PVLA
767
Palvella Therapeutics
PVLA
$2.23B
$114 ﹤0.01%
+1
New +$80
TXG icon
768
10x Genomics
TXG
$7.52B
$109 ﹤0.01%
+3
New +$98
SE icon
769
Sea Limited
SE
$78.5B
$104 ﹤0.01%
+2
New +$108
HRTX icon
770
Heron Therapeutics
HRTX
$64.7M
$100 ﹤0.01%
+40
New +$129
DWX icon
771
State Street SPDR S&P International Dividend ETF
DWX
$529M
$97 ﹤0.01%
3
-50
-94% -$1.55K
TDOC icon
772
Teladoc Health
TDOC
$1.22B
$95 ﹤0.01%
+4
New +$108
CABA icon
773
Cabaletta Bio
CABA
$465M
$93 ﹤0.01%
+10
New +$36
SRNE
774
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$89 ﹤0.01%
+100
New +$133
BABA icon
775
Alibaba
BABA
$300B
$88 ﹤0.01%
+1
New +$79

Similar funds

NewSquare Capital's Q4 2022 Portfolio in Review

As of Q4 2022, NewSquare Capital held 886 positions worth $802M, up 0.2% from $800M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

NewSquare Capital withdrew a net $61.5M in Q4 2022, closing 55 positions and reducing 137 holdings. Its most notable exit was Arista Networks, an estimated $2.79M position sold in full.

By sector, the portfolio is most concentrated in Financials at 6.5% of assets, up from 5.9% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, NewSquare Capital opened a new position in State Street SPDR FTSE International Government Inflation-Protected Bond ETF worth $6.97M.

  • NewSquare Capital's largest Q4 2022 buy was State Street SPDR FTSE International Government Inflation-Protected Bond ETF: 169,210 shares worth $6.97M.
  • NewSquare Capital added most to Invesco Dorsey Wright Developed Markets Momentum ETF in Q4 2022, an estimated $9.39M increase.
  • NewSquare Capital's biggest Q4 2022 reduction was Invesco S&P 500 Low Volatility ETF, cutting an estimated $17.2M.
  • NewSquare Capital fully exited Arista Networks in Q4 2022, selling an estimated $2.79M.
  • NewSquare Capital's ten largest holdings make up 30% of its $802M portfolio in Q4 2022.
  • NewSquare Capital opened 409 new positions and closed 55 in Q4 2022.
  • NewSquare Capital's portfolio value rose 0.2% quarter-over-quarter to $802M.

Based on NewSquare Capital's 13F filing for Q4 2022, filed 7 Feb 2023.